Variant · Snv
TP53 NM_000546.6(TP53):c.920-2A>G
CI-VAR-00008533Explore in graph →NM_000546.6:c.920-2A>GClinVar 43595 rs397516439
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 43595 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Li-Fraumeni syndrome; Hereditary cancer-predisposing syndrome; Ovarian neoplasm; Breast and/or ovarian cancer; Li-Fraumeni syndrome 1; Familial cancer of breast; Squamous cell carcinoma of the head and neck; Ovarian serous cystadenocarcinoma; Lung cancer; Neoplasm; Squamous cell lung carcinoma; Hepatocellular carcinoma | germline/somatic | 13 | Mar 10, 2026 | clinvar |